Price movement over the last 24 hours
ProShares Ultra Silver ETF vs Pfizer Inc — how do they compare? ProShares Ultra Silver ETF trades at $65.75, while Pfizer Inc trades at $24.08 (market cap $137.19B). The key difference: Pfizer Inc pays a 7.15% dividend while ProShares Ultra Silver ETF pays none. Which is the better fit depends on your goals.
| AGQ | PFE | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $400.47 | $28.56 |
52-Week Low | $48.15 | $23.29 |
Market Cap | — | $137.19B |
Volume | — | 29,869,932 |
Enterprise Value | — | $187.84B |
Dividend Yield | — | 7.15% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Pfizer (PFE) trades at $24.04, up 1.35% on the day, with a bearish technical signal despite recent earnings beats. The company maintains solid fundamentals with a P/E of 18.37 and net margin of 11.83%, supported by strong cash flow from operations of $11.70B in 2025. Recent news highlights pipeline developments in oncology and obesity treatments, positioning for future growth amid patent cliff challenges.
The outlook balances a discounted valuation against near-term revenue pressures. Opportunities include a rich product pipeline and sustainable dividend yield, while risks involve patent expirations and competitive threats. Analyst consensus leans neutral with a $27.63 price target, suggesting cautious optimism for recovery.
Trailing returns across standard periods
Latest headlines on both assets
AGQ is a leveraged ETF that seeks daily investment results corresponding to two times (2x) the daily performance of silver bullion. It is designed for investors seeking magnified short-term exposure to silver prices.
Read more on AGQ →Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →